Pharma: Other News To Note

• Astellas Pharma Inc., of Tokyo, said the European Commission approved expanded options for pre-treatment prior to use of Qutenza (8 percent capsaicin patch). Before application, the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anesthetic.